Scientifi c literature shows that infl ammation and oxidative stress contribute in the pathogenesis of atherosclerosis. Th e oxidative stress is the consequence of an imbalance between the free radical generation and elimination. One source of free oxygen radicals is cyclooxygenase (COX) - and, therefore, inhibiting the activity of this enzyme is likely to reduce oxidative stress. In the present study an experimental rabbit model of hypercholesterolemia was developed and the eff ects of COX- inhibitors, nimesulide and celecoxib were observed on the activities of antioxidant enzymes, superoxide dismutase (SOD), glutathione peroxidase (GPx) and total antioxidant status (TAS). Rabbits were divided into four groups-control, saline, nimesulide and celecoxib, with all groups fed a high cholesterol diet, which only received saline. Low activities of SOD, GPx and TAS were measured in the hypercholesterolemic rabbits pretreated with saline. In the same group, a reciprocal relationship was observed between the LDL-cholesterol concentration and the plasma activities of GPx, SOD and TAS. Rabbits in nimesulide and celecoxib group showed signifi cantly higher activities of SOD, GPx and TAS in hypercholesterolemic rabbits compared to saline group (p<.). Our study shows that selective and timely use of COX- inhibitors would be useful in preventing the onset and development of atherosclerosis by enhancing antioxidant defence system.
INTRODUCTION
Infl ammation and oxidative stress are intimately involved in the pathogenesis of atherosclerosis [] . In hypercholesterolemia, generally recognized as a risk factor of atherogenesis, oxidative stress plays an important role [] . Th e tissue concentration of oxygen radicals is limited under normal physiological conditions due to the existence of a delicate balance between the generation of free radicals and the antioxidant defense system [] . However, if this balance is perturbed in favour of more free radicals, either through an enhanced production or via a reduction in the endogenous antioxidant defence system or both, the body is at risk for free radical-mediated cell damage. In this scenario, an important pathogenic role of these free radicals is a harmful oxidative modifi cation of low-density cholesterol (LDL) . Th e involvement of reactive oxygen species (ROS) in the oxidative modifi cation of LDL is an important element of atherogenesis. Th ese ROS has drawn attention to the anti-oxidative defence of the organism, including the so-called ROS scavengers. Among natural, so-called primary scavengers, antioxidative enzymes of red blood cells and of the serum play a major role [] . Endothelial damage and increase in polymorphonuclear leukocyte activity which occur during atherogenesis lead to oxidative stress and to an overproduction of reactive forms of oxygen, which in turn exhaust the anti-oxidative pool of the organism. Total antioxidant status (TAS), glutathione peroxidase (GPx) and superoxide dismutase (SOD) are largely responsible for maintaining the redox balance within the body [] . Patients with ischemic heart disease are detected with the presence of low SOD [] . Th e incidence of cardiovascular diseases such as atherosclerosis increases with low levels of GPx [] . Mitrevky and colleagues reported low TAS levels in patients with myocardial infarction [] . Low TAS level is also found in patients with atherosclerosis [] , in cancer and rheumatoid arthritis patients [] , in male infertility and diabetic patients [, ] . One source of free oxygen radicals is cyclooxygenase (COX) - and, therefore, inhibiting the activity of this enzyme is likely to reduce oxidative stress. However, whether COX- inhibitors aff ect the activity of antioxidant enzymes during hypercholesterolemia has not been investigated with any rigor. In the present study an experimental rabbit model of hypercholesterolemia was developed and the effects of COX- inhibitors nimesulide and celecoxib were observed on the activities of above-mentioned antioxidant enzymes.
MATERIALS AND METHODS

Animals
Male New Zealand white rabbits weighing .- kg were kept in the Animal House of Kohat University of Science & Technology, Kohat, Pakistan for at least  days before any experiment. Rabbits were divided into four groups. First group was fed standard rabbit diet (control group), second group was maintained on high cholesterol supplemented diet ( cholesterol diet, Harlan Teklad, WI, USA) and pre-treated with saline (saline group), third group was maintained on high cholesterol supplemented diet and pretreated with nimesulide (nimesulide group) while fourth group was maintained on high cholesterol supplemented diet and pretreated with celecoxib (celecoxib group).
Procedures
Control and saline groups were injected subcutaneously with . ml saline per rabbit per day while nimesulide and celecoxib groups were injected with nimesulide ( mg/ kg) per rabbit per day and celecoxib ( mg/kg) per rabbit per day throughout the  weeks of experimental period. Both nimesulide and celecoxib were dissolved in  DMSO (final concentration). Doses of  mg/kg for nimesulide and celecoxib administered to the animals were calculated on the basis of recommended daily doses of these drugs in human, and interpolated to rabbits. This protocol was approved by the Animal Committee of Kohat University of Science & Technology. All rabbits were given free access to food and water. Overnight fasting blood was collected from all groups before feeding the normal or high cholesterol diet and pretreatment with COX  inhibitor and after , , , , , , , ,  and  weeks. Blood was taken from the marginal ear vein of these animals and then transferred into siliconized glass tubes. Lipid profi le and antioxidant assays were performed within two hours of the blood collection. All the animals used in this study were handled in compliance with the highest ethical guidelines by the National Institute of Health USA, for the care of such animals. Following experiments were carried out on the blood of all rabbits.
Lipid profi le
Total cholesterol, HDL and LDL concentrations were determined using routine spectrophotometric assays from kits purchased from RANDOX, UK, and as described by Ukpanukpong et al. [] .
Glutathione peroxidase activity
GPx activity was measured as described by Gul et al. [] . The assay works by the addition of t-butyl-hydroperoxide which is a substrate for GPx. In this assay the peroxidase reaction is coupled with reductase reaction. Glutathione is used as co-substrate. A change in the absorbance at  nm takes place after the reduction of the substrate. This change in the absorbance is reflective of GPX activity.
Superoxide dismutase activity SOD activity was determined as described by Gul et al. [] . In this experiment formazane dye is obtained by the addition of the substrate (i.e. -(-iodophenyl)--(-nitrophenol)--phenyltetrazoliumchloride (INT)) and after the addition of all other contents of the kit. Th e basic principle of the method is the generation of superoxide radicals with xanthine and xanthine oxidase. Th is reaction is inhibited depending upon the concentration and activity of SOD. The absorbance at  nm measures the activity of SOD.
Total antioxidant status
TAS assay was performed as described by Gul et al. [] . Th is experiment is based on the chemical (,' azino-bis-[-ethylbenz-thiazoline--sulfonic acid] (ABTS)) which is used as a substrate in the reaction. After the addition of plasma and other kit contents, ABTS is added at the very end. As soon as ABTS is added, oxidants in the plasma start oxidizing it to ABTS+. A change in the absorbance at  nm shows the degree of inhibition by plasma antioxidants and indicates TAS levels in the plasma. The final plasma antioxidant concentration is obtained by multiplying the absorbance of the sample to the specifi c factor obtained from the standard and the blank and measured in (mmol/L).
Statistical analysis
Statistical analysis was done by one-way analysis of variance (ANOVA) flowed by the Newmal -Keuls test. p<. was considered significant. All the experiments were performed in triplicate.
RESULTS
Lipid profi le
Th ere was no signifi cant change in total cholesterol levels in control group throughout the study while in saline group total cholesterol increased signifi cantly to .±. mM and .±. mM at week  and  respectively (Table  ) . In nimesulide group, .±. mM and .±. mM total cholesterol levels were observed at week  and  respectively and were signifi cantly lower than in the saline group. In celecoxib group .±. mM and .±. mM levels were observed at week  and  respectively indicating significant lowering compared to saline group at week . In saline group, HDL cholesterol decreased to .±.mM and .±. mM at week  and  respectively, in nimesulide group, it increased to .±.mM and .±. mM at week  and  respectively while in celecoxib group, .±. mM and .±. mM of HDL cholesterol was observed at week  and  respectively. LDL cholesterol increased in the saline group to .±. mM and .±.) mM at week  and  respectively, to .±. mM and .±. mM at week  and  respectively in nimesulide group while increased to .±. mM and .±. mM at week  and  respectively in celecoxib group (Table ) . However, this increase in LDL-cholesterol in nimesulide and celecoxib groups was signifi cantly lower (p<.) compared to the increase in the saline group at week  and . All the results are expressed as mean ± S.D.
Total antioxidant status (TAS)
In hypercholesterolemic rabbits treated with nimesulide, there was signifi cant elevation of TAS from . ± . to maximum of . ± . mmol/L of plasma at week  (p<. compared to saline treated hypercholesterolemic rabbits) (See Figure  and Table  ). In the control animals fed on the standard diet, TAS remained roughly the same throughout the study with slight increase from . ± . at week  to a maximum value of . ± . mmol/L of plasma at week . In hypercholesterolemic rabbits treated with saline, TAS decreased slightly from . ± . to . ± . mmol/L of plasma at week . In hypercholesterolemic rabbits treated with celecoxib, TAS increased from . ± . at week  to a maximum value of . ± . mmol/L of plasma at week  (p<. compared to saline treated hypercholesterolemic rabbits). All the results are expressed as mean ± S.D. 
Glutathione peroxidase (GPx)
The cholesterol-rich diet resulted in the elevation of the GPx from  ±  to  ±  U/L of hemolysate at week  in hypercholesterolemic rabbits treated with nimesulide (p<. compared to saline treated hypercholesterolemic rabbits) (See Figure  and Table  ). In the control animals fed on the standard diet, there were slight changes in GPx but mostly remained unchanged and increased slightly from  ±  to  ±  U/L of hemolysate at week . In hypercholesterolemic rabbits treated with saline, GPx decreased from  ±  at week  to  ±  U/L of hemolysate at week . In hypercholesterolemic rabbits treated with celecoxib, GPx increased from  ±  at week  to  ±  U/L of hemolysate at week  (p<. compared to saline treated hypercholesterolemic rabbits). All the results are expressed as mean ± S.D.
Superoxide dismutase (SOD)
In hypercholesterolemic rabbits treated with nimesulide, there was significant elevation of the SOD from  ±  to ± U/L of whole blood at week  (p<. compared to saline treated hypercholesterolemic rabbits) (See Figure  and Table  ). In the control animals fed on the standard diet, SOD increased slightly from  ±  to  ±  U/L of whole blood at week . In hypercholesterolemic rabbits treated with saline, SOD decreased TAS measured in (mmol/L) at a given week; SD is standard deviation while n refers to the number of animals in each group at a given week.
FIGURE 2. GPx levels of rabbits in group A (normal) group B (hypercholesterolemia and saline treated), group C (hypercholesterolemia and nimesulide treated) and group D (hypercholesterolemia and celecoxib treated). *p< 0.05 compared to control group in the same week.
from  ±  at week  to  ±  U/L of whole blood at weeks  and . In hypercholesterolemic rabbits treated with celecoxib, SOD increased significantly from  ±  at week  to  ±  U/L of whole blood at week  (p<. compared to saline treated hypercholesterolemic rabbits).
All the results are expressed as mean ± S.D.
DISCUSSION
Various factors, both intrinsic and extrinsic, can influence the activity of antioxidative enzymes [] . Studies indicate an inverse relationship between cholesterol concentration and antioxidant enzymes including SOD, GPx and TAS [, ] . Th erefore, people with high LDL-CH can have decreased activity enzymes of antioxidative defence system. This also indicates that such people have an excess of substrate, which is likely to be modifi ed by the oxidative agents [] . Consistent with previous studies [, ] , we observed a reciprocal relationship between the levels of LDL cholesterol and the plasma activities of GPx, SOD and TAS in saline treated hypercholesterolemic rabbits (see Table  ).
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GPx measured in (U/L) at a given week, SD is standard deviation while n refers to the number of animals in each group at a given week.
FIGURE 3. SOD levels of rabbits in group A (normal) group B (hypercholesterolemia and saline treated), group C (hypercholesterolemia and nimesulide treated) and group D (hypercholesterolemia and celecoxib treated). *p< 0.05 compared to control group in the same week.
involvement of hyperlipidemia in lowering the enzymatic antioxidative pool in persons with atherosclerosis is clear, it is never quantitatively estimated [] . Th e conditions favoring ROS overproduction with concomitant exhaustion of enzymatic antioxidative pool and the results presented here point to a major role of hypercholesterolemia in lowering the activities of SOD and GPx and TAS. It is diffi cult to evaluate to what extent a decrease in the respective values can participate in the initiation of the atherosclerotic cascade. Nevertheless it is evident that enzymatic antioxidative activity is decreased in hypercholesterolemic rabbits which can facilitate and augment the atherosclerotic process. Whether or not the measurements of antioxidative activities of SOD and GPx and TAS can be used in the diagnosis of coronary atherosclerosis in persons with hypercholesterolemia requires further studies. Th ere are some studies, which show a decrease in GPx, SOD and TAS in coronary heart disease population [] but most of these studies take single measurements. Since atherosclerosis is a chronic process, single measurements of lipids, SOD, GPx, and TAS as well as other risk factors at a particular stage do not allow inferences of their past infl uence on the disease's progression [] . Th erefore, we took measurements periodically after  weeks up to th week. Th e considerable decrease in the activities of SOD, GPx and TAS in hypercholesterolemic group suggests that a weakening or destruction of the antioxidative barrier of the organism is related to hypercholesterolemia. In nimesulide treated hypercholesterolemic rabbits and to a lesser extent in celecoxib treated hypercholesterolemic rabbits, activities of GPx, SOD and TAS were improved as compared to the saline treated hypercholesterolemic rabbits suggesting antioxidative potential of these COX- inhibitors. Our study does not point to the mechanism of antioxidant actions observed with nimesulide and celecoxib. Previous studies, however, show that COX inhibition is associated with improvement in cardiovascular diseases [, ] . COXmetabolites infl uence the force of myocardial contractions through oxidative stress and by aff ecting changes in Ca+ cycling [, ] . Prostaglandins produced by the action of COX cause induction and growth of infl ammatory mediators and their reduction or inhibition by COX- inhibitors reduces not only infl ammation, but also oxidative stress [] . Oxidative stress also adversely aff ects the structure and function of myocardium [] and COX- inhibitors, by causing a reduction in oxidative stress [] may improve the myocardial contractility. In patients with coronary artery disease, endothelial function was improved by celecoxib mainly through reducing oxidative stress [] . Selective inhibition of COX- is shown to be benefi cial in the treatment of myocardial infarction as induction of COX- in the ischemic myocardium is followed by oxidative stress [, ] . However, further studies are needed to decipher the exact mechanism of these eff ects of COX- inhibitors in improving antioxidative defence system. WEEKS  CONTROL  SALINE  NIMESULIDE  CELECOXIB  SOD  SD  n  SOD  SD  n  SOD  SD  n  SOD  SD  n  0  180  21  12  178  20  12  179  18  12  179  12  12  2  175  19  12  165  16  12  180  24  12  184  13  12  4  174  18  11  162  17  12  197  27  12  185  12  12  6  178  17  11  169  15  12  204  19  12  188  16  12  8  180  19  11  162  17  11  210  17  11  198  21  11  10  186  15  10  167  15  11  225  16  11  203  14  11  12  188  15  10  165  19  11  227  18  11  210  15  11  14  184  17  10  166  14  10  229  24  11  212  14 SOD measured in (U/mL) at a given week, SD is standard deviation while n refers to the number of animals in each group at a given week. 
